Prostate Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Prostate Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: High-Risk prostatE Cancer radiatiOn Versus surgERy
A clinical trial in the Netherlands is recruiting to compare radiotherapy versus surgery for high-risk prostate cancer.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial [Phase 2]
Phase 2 placebo-controlled trial evaluating Urolithin A supplementation in men with prostate cancer undergoing radical prostatectomy (URO-PR…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating sequencing abemaciclib before 177Lu-PSMA-617 for metastatic castration-resistant prostate cancer, w…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study [Phase 2]
A Phase 2 clinical trial update evaluating the addition of Relugolix to standard radiation therapy for advanced, oligometastatic prostate ca…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes [Phase 2]
A Phase 2 clinical trial evaluating intermittent fasting with a fasting-mimicking diet to improve prostate cancer control and metabolic outc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Clinical Trial of Green Tea Catechins in Men on Active Surveillance [Phase 2]
A Phase 2 clinical trial update evaluating green tea catechins for men with prostate cancer on active surveillance; the study is currently a…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer [Phase 2]
A Phase 2 trial evaluating a combination of apalutamide, abiraterone acetate, and prednisone in metastatic castration-resistant prostate can…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer [Phase 2]
This Phase 2 clinical trial evaluates enzalutamide combined with relacorilant versus placebo for patients with high-risk localized prostate …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) [Phase 2]
This entry covers a Phase 2 clinical trial evaluating Bipolar Androgen Therapy (BAT) in combination with Radium-223 for metastatic castratio…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating BL-B01D1 in patients with metastatic or unresectable non-small cell lung cancer and other solid tumors is …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of vorinostat and Lutetium-177 PSMA-617 for PSMA-low metastatic castration-resistant pro…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer [Phase 2]
This is a Phase 2 clinical trial update examining strategic endocrine therapy with targeted radiotherapy for prostate cancer. The study stat…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors [Phase 2]
This phase 2 trial update investigates nivolumab with docetaxel and androgen deprivation therapy in men with hormone-sensitive or metastatic…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Prostate Cancer (CaP)
A Mayo Clinic-sponsored clinical trial update reports on the feasibility of a patient-centered home care model to reduce disparities among h…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer [Phase 2]
This report describes an ongoing Phase 2 clinical trial evaluating risk-stratified de-escalated hormone therapy in combination with radiatio…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) [Phase 1, Phase 2]
A Phase 1/2 clinical trial of HLD-0915 for metastatic castration-resistant prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
This ClinicalTrials.gov update describes the ARCTIC study from Duke University, a prospective set of trials investigating liquid biomarkers …
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer
The update describes an ongoing clinical trial evaluating PSMA PET imaging in people with prostate cancer, with the study currently active b…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers [NA]
A multi-cancer prospective study evaluating double-positive circulating cells (CD45+ tumor marker) in several types of metastatic cancers; r…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: PSMA PET Imaging of Recurrent Prostate Cancer [Phase 2]
This update reports on a Phase 2 clinical trial evaluating PSMA PET imaging in recurrent prostate cancer.
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048) [Phase 1]
A Phase 1 clinical trial evaluating hypofractionated accelerated pelvic nodal radiotherapy (GCC 2048) for prostate cancer is currently recru…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: The Use of Ultrasound in Assessing Post-prostatectomy Erectile Dysfunction [NA]
A Mayo Clinic clinical trial is evaluating ultrasound as a method to assess erectile dysfunction after prostate cancer surgery. The study is…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: 177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study [Phase 2]
The LUNAR study is a Phase 2 trial evaluating 177Lu-PSMA therapy before stereotactic body radiotherapy in oligometastatic or recurrent prost…
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies
An update on an observational clinical trial studying patients with metastatic prostate adenocarcinoma that is resistant to castration and m…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: CyberKnife Dose Escalation Prostate Cancer Trial [NA]
This document reports an ongoing CyberKnife dose-escalation trial for prostate cancer that is currently not recruiting.